Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
Number | Exp. Date | Activity Code(s) Sort ascending | Title |
---|---|---|---|
PAR-22-101 | October 18, 2024 | R21 | Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) |
PAR-22-109 | May 8, 2025 | R21 | Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) |
NOT-OD-22-142 | March 17, 2025 | R21 | Notice of Special Interest (NOSI): Community-Based Participatory Research (CBPR) Initiative in Reducing and Eliminating Health Disparities with a focus on addressing diverse representation in research on Down syndrome (R21 Clinical Trial Optional) |
PAR-24-161 | May 8, 2027 | R21 | New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional) |
RFA-MH-25-171 | October 10, 2026 | R21 | BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R21 Clinical Trial Optional) |
PAR-21-355 | November 17, 2024 | R21 | Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional) |
PAR-23-131 | May 8, 2026 | R21 | Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) |
NOT-OD-24-026 | July 16, 2024 | R21 | Notice of Special Interest (NOSI): Advance Data Science Approaches Through Secondary Data Analysis to Reveal Scientific Insights of COVID-19 Testing Technologies (R21) |
RFA-OD-23-013 | June 21, 2024 | R21 | Understanding Chronic Conditions Understudied Among Women (R21 Clinical Trial Optional) |
PA-20-196 | January 8, 2025 | R21 | NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required) |
PAR-23-294 | November 19, 2026 | R21 | Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) |
PAR-24-046 | November 20, 2024 | R21 | Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed) |
PAR-24-045 | November 20, 2024 | R21 | Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed) |
PAR-23-159 | October 18, 2024 | R21 | Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) |
PAR-23-299 | January 8, 2027 | R21 | Intervention Research to Improve Native American Health (R21 Clinical Trials Optional) |
PA-20-195 | January 8, 2025 | R21 | NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) |
RFA-MH-25-186 | August 14, 2024 | R21 | Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Optional) |
PA-20-194 | January 8, 2025 | R21 | NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) |
RFA-EY-23-001 | June 16, 2026 | R21 | BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) |
PAR-23-296 | September 8, 2026 | R21 | Opportunities for HIV Cure Strategies at the Time of ART Initiation (R21 Clinical Trial Not Allowed) |